Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Go back to Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
(NASDAQ: VRDN) Delayed: 22.92 --0 (-0%)
Previous Close $22.92    52 Week High
Open $22.92    52 Week Low
Day High $22.92    P/E N/A 
Day Low $22.92    EPS
Volume 12,623